Share this:
Research shows why cancer stops responding to kinase-blocking drugs and comes back stronger
More than 70 FDA-approved cancer drugs are kinase inhibitors, which work by blocking kinases — enzymes that add phosphate groups to molecules in the cell — and preventing the chemical activity necessary for signaling and growth in cancer cells…
Published March 13, 2023 at 09:45AM
Read more at nsf.gov
More Stories
Deep brain stimulation during sleep strengthens memory
Overfishing linked to rapid evolution of codfish
NSF Director Panchanathan joins Rep. Cartwright in Pennsylvania for Engine kickoff